ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...
Using Miebo during the lead-up to cataract surgery has no impact on the accuracy of preoperative measurements, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback